Perrigo

HRA Pharma Seeks FDA Approval for OTC Contraceptive

In the wake of the US Supreme Court’s recent overturn of Roe v. Wade, a 50-year-old decision by an earlier team of justices that guarantees women the right terminate a pregnancy, attention has turned to the so-called morning-after pill mifepristone – which remains legal for now – and easier access to birth control.

Perrigo to Separate Prescription Pharmaceuticals

SK Capital Changes Tack on Archroma

Valeant Names New Finance Chief

Valeant on Verge of Hiring Perrigo’s CEO?

Mylan to Buy Sweden’s Meda for $9.9 Billion

AstraZeneca and Sanofi Swap Compounds

Mylan Bid for Perrigo Fails

Court Says Mylan Can Uphold Perrigo Bid

Mylan Makes New Bid for Perrigo

Perrigo Acquires Scar Management Brand

M&A Carousel Turns Faster as Deals Set New Records

Teva to Acquire the Generics Activities of Allergan for Over $40 Billion

Teva and Mylan Slug it out Over Takeover Bid

Perrigo Buying GSK, Novartis Consumer Brands

Mylan Sweetens its Bid for Perrigo

Mylan Said to Prepare Poison Pill Potion Against Teva

Teva Makes $40 Billion Cash-and-Stock Bid for Mylan

Mylan Makes $29 Billion Bid for Perrigo

Germany's Merck Plans to Expand in Consumer Health

Perrigo to Acquire Omega Pharma for €2.48 Million

Boehringer Not Bidding for Belgian Drugmaker

U.S. Supreme Court Win Boosts Fight Against Drug Settlements

U.S. Warns Perrigo Over Ongoing Manufacturing Lapses